Advances in Myiasis Treatment
Biomedical Science, Swansea University, United Kingdom
- Corresponding Author:
- Nigam Y
Associate Professor Biomedical Science, Leader of Swansea Maggot Research Group
Room 215, Vivian Tower, College of Human and Health Science, Swansea University
Singleton Park, Swansea Wales, SA2 8PP
Tel: +44(0)1792 518565
E-mail: [email protected]
Received date: February 09, 2016; Accepted date: February 25, 2016; Published date: March 03, 2016
Citation: Nigam Y (2016) Advances in Myiasis Treatment. Health Care: Current Reviews 4:161. doi:10.4172/2375-4273.1000161
Copyright: © 2016 Nigam Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The maggots of the green bottle fly, Lucilia Sericata, have been crawling around the world for about two hundred million years. Following the evolution of man, a relationship developed between these maggots and the wounds of man. An acceptable sort of myiasis was born. In the last decade, the level of evidence recording successful outcomes of clinically applied, artificially induced myiasis on wounds using this medicinal maggot, has expanded greatly. And as modern and advanced technology helps science to unlock more doors, we are able to gain a clearer picture of the molecules and biochemical pathways by which maggots exert their effects; studies which hopefully will enrich our understanding of the clinical effects observed. The following commentary précises such new developments and summarises our current thinking on maggot / larval therapy.